Comment from Alliance for Pharmacy Compounding
AnonymousSupportAdvocacy
Summary: The Alliance for Pharmacy Compounding (APC) supports the inclusion of certain peptides on the FDA's bulk drug substance list for compounding. They argue that providing a regulated, professional pathway for these substances is a public health necessity to move patients away from unregulated and illicit marketplaces.
This comment, submitted by the Alliance for Pharmacy Compounding (APC), addresses the Pharmacy Compounding Advisory Committee's upcoming review of certain peptide substances for potential inclusion on FDA's compounding bulk drug substance list.